The abstract is read at the publisher; the summary is JClub's.
Formicitoxins-35, membrane-targeting venom peptides from carpenter ants, are the first reported from any formicine species and include variants that outperform voriconazole.
- Why it matters: Antifungal options are limited to three drug classes, so new agents are needed that work against fungal infections without relying on existing drug targets.
- What they did: Koch et al. identified formicitoxins-35 from carpenter ant venoms and tested their antifungal activity in vitro against fungi and in vivo by delaying infection.
- The result: The peptides disrupt fungal membranes independently of existing drug targets, and two variants both outperform voriconazole in vitro and delay infection in vivo.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.